Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances
Mediterranean Journal of Nutrition and Metabolism · 19.05.2011 · 4 (3) · 211-218
DOI: 10.3233/s12349-010-0045-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Mediterranean Journal of Nutrition and Metabolism, online erschienen am 17.12.2010. Verfasst von Julien Cases und 4 weiteren Autor:innen. Die Arbeit wurde bisher 36-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Botanicals are an alternative option to prescription drugs for the alleviation of symptoms due to anxiety disorders and insomnia. Melissa officinalis L. has been shown as an anti-stress and anxiolytic agent. We previously reported moderate stress improvement in mice in which Cyracos ® , a standardized Melissa officinalis L. extract, was administrated. Cyracos ® contains phytochemicals that inhibit gamma-aminobutyric acid catabolism. This was a prospective, open-label, 15-day study to evaluate the efficacy of Cyracos ® on stressed volunteers, who have mild-to-moderate anxiety disorders and sleep disturbances. Using clinician rating criteria, primary outcomes showed improvement of symptoms. Cyracos ® reduced anxiety manifestations by 18% (p < 0.01), ameliorated anxiety-associated symptoms by 15% (p < 0.01) and lowered insomnia by 42% (p < 0.01). As much as 95% of subjects (19/20) responded to treatment, of which 70% (14/20) achieved full remission for anxiety, 85% (17/20) for insomnia, and 70% (14/20) for both. Our study demonstrates, for the first time that chronic administration of Melissa officinalis L. relieves stress-related effects. It is critical that further studies incorporate a placebo and investigate physiological stress markers.
Zitieren
APA
Cases, J., Ibarra, A., Feuillère, N., Roller, M., & Sukkar, S. G. (2011). Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterranean Journal of Nutrition and Metabolism, 4(3), 211-218. https://doi.org/10.3233/s12349-010-0045-4
Vancouver
Cases J, Ibarra A, Feuillère N, Roller M, Sukkar SG. Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances. Mediterranean Journal of Nutrition and Metabolism. 2011;4(3):211-218. doi:10.3233/s12349-010-0045-4
BibTeX
@article{Cases2011,
author = {Cases, Julien and Ibarra, Alvin and Feuillère, Nicolas and Roller, Marc and Sukkar, Samir G.},
title = {Pilot trial of Melissa officinalis L. leaf extract in the treatment of volunteers suffering from mild-to-moderate anxiety disorders and sleep disturbances},
journal = {Mediterranean Journal of Nutrition and Metabolism},
year = {2011},
volume = {4},
number = {3},
pages = {211--218},
doi = {10.3233/s12349-010-0045-4}
}
EUVIMED